OptimizeRx - Learning Together: Navigating the COVID-19 Pandemic OptimizeRx

Launching a new medication in a complex disease state is fraught with complications that can impact medication adherence. New medications that can greatly improve a patient’s quality of life and overall health can present significant side effects that often lead patients to abandon treatment. When patients are faced with a life-threatening disease, unexpected or misunderstood side effects from medication can trigger fear that the medication is having an adverse effect, or worsening their condition.

In this webinar, we’ll discuss innovative and best-in-practice approaches to new drug launches that explore the art, science, and psychology to treatment and medication adherence. Join this incredible panel of industry experts and thought leaders with decades of experience in innovative drug launches. We’ll explore the complexities and opportunities for life science companies to deliver new programs that achieve positive outcomes – for patients and their care teams.

During this webinar our panelists will review a special case study of a highly successful patient engagement program that combined nurse support with text-based communication, leading to over 34% engagement and averaging 14 minutes per session. This innovative program helped patients successfully navigate the side effects of treatment and stay adherent on life-extending therapy. The industry benchmarks for patient engagement and adherence are being redefined by such programs.

Guests:


Eugene Borukhovich, Chairman & COO: YourCoach.Health, former Global Head Digital Health, Bayer
Chris DiCostanzo, Vice President, Client Relations, OptimizeRx
Mary Anne Greenberg, CEO, Diligent Health Solutions

Moderated by Rebecca Love, MSN, RN, Principal, Clinical Innovations, OptimizeRx and Mark Bard, Co-Founder, The DHC Group
Send your questions to webinars@optimizerx.com 

Visit www.OptimizeRx.com/webinars for more insightful industry conversations. 

Follow us on Twitter and LinkedIn

As we re-open the country, what is the role of tracing, tracking and testing as we manage COVID-19? How do we weigh safety vs. risk, and public health vs. economic impact?  We're bringing together three leading experts in tracing, tracking, and testing to tell us how tech is transforming these methodologies to ramp up the ability to open safely. We'll also discuss:


The importance of tracing, tracking and testing in a pandemic

What we’re learning from other nations

The challenges we’re facing

What early learnings we can draw from this pandemic that could help us in future

Traditional methodologies for tracing, and how technology is changing them

Privacy issues we should consider when discussing technology’s role in tracking, tracing and testing


Panelists

John Werner, Managing Director, Link Ventures, CNO& SVP, Cogo Labs.

Gabor Bethlendy, CEO & Founder, Meenta, former CCO & Founder of Parabase Genomics.

Greg Nadeau, Program Manager, PathCheck

Moderated by Rebecca Love RN, MSN, FIEL, Vice President Customer Strategy and Engagement, OptimizeRx



Send your questions to webinars@optimizerx.com

Visit www.OptimizeRx.com/webinars for more insightful industry conversations.

Follow us on Twitter and LinkedIn

With healthcare on the front lines of the COVID-19 pandemic, the ways in which we communicate have been drastically altered, and finding new ways to connect with patients and providers has become paramount. In the face of this new communication landscape, companies are looking to do more with less, embracing flexibility and the power of digital tools to keep vital health and treatment information flowing. In this session, we will explore how different life science companies are navigating these changes, how digital plans can help (and how they can't), and provide thoughtful conversation on the ways in which healthcare must adapt moving forward.   

Guests: 


Karima Sharif, Group Vice President, Publicis Health Media
Steve Silvestro, Chief Commercial Officer, OptimizeRx
Paul Ivans, Founder & CEO, Evolution Road
Eze Abosi, Vice President, OptimizeRx

Moderated by Kara Giannecchini, Senior Manager Haymarket Studio, MM&M

You can send your questions to webinars@optimizerx.com   

Visit www.OptimizeRx.com/webinars for more insightful industry conversations around the COVID-19 pandemic and make sure to follow us online and subscribe!    

Follow us on Twitter and LinkedIn

In the face of social distancing to prevent further spread of coronavirus, telemedicine has emerged as the best, and most viable method to ensure patients have access to medical consults and care. And while this is by no means new technology, it is experiencing unprecedented demand and ease of regulations to help support our healthcare system during this crisis. But will these temporary changes pave the way to a more permanent place at the table for telemedicine? And will broader telehealth initiatives persist after the pandemic subsides?

In this episode, we discuss the intricacies and opportunities of this extraordinary moment for telemedicine, the growing importance of virtual care and its place in telehealth, and what these changes imply for the healthcare industry as a whole.



Guests:


Carla Smith, CEO of Carla Smith Health, Senior Advisor to Springboard Enterprises Life Sciences Council, CareTeam Technologies Inc, b.well Connected Health, among others; former Executive Vice President of HIMSS.

Randy Parker, CEO of Genius Rx, Founder & CEO of MDLIVE, Strategy Advisor at high.


Moderated by Miriam Paramore, President, OptimizeRx 



Send your questions to webinars@optimizerx.com

Visit www.OptimizeRx.com/webinars for more insightful industry conversations.

Follow us on Twitter and LinkedIn

COVID-19 has become a disruptive force to the world as we know it. Beyond being disruptive, COVID-19 is proving to have a transformational impact on many industries—starting with healthcare.

From unprecedented real-time scientific collaboration across the globe to relaxed regulations, new supply chain, and PPE sourcing opportunities, to a deeper reliance on digital communication than ever before, COVID-19 is transforming the way healthcare works. In this engaging discussion, we’ll address how this disruption is providing opportunities for new technologies, startups, and innovation to thrive, diving into some of the ways healthcare is adjusting and transforming at every level.

We invite all in healthcare—digital and beyond—to join us as we continue our practical conversations series with industry leaders, exploring the transformational trends and changes that are occurring in our healthcare ecosphere today.

Guests:


Chandana Fitzgerald, Chief Medical Officer, HealthXL

David Chang, Entrepreneur & Angel Investor, Former Chief Operating Officer of PayPal, and current Board Member of Harvard Ventures, MITX & Flybridge Capital Partners among others.

Shawna Butler, RN, MBA, Exponential Medicine Partnerships and Outreach, Singularity University


Moderated by Rebecca Love RN, MSN, FIEL, Vice President Customer Strategy, and Engagement, OptimizeRx

Send your questions to webinars@optimizerx.com

Visit www.OptimizeRx.com/webinars for more insightful industry conversations.

Follow us on Twitter and LinkedIn

We continue tackling the challenges and potential solutions for frontline healthcare providers (HCPs) facing the COVID-19 pandemic. In this episode we'll discuss how healthcare leaders are maximizing the power of digital tools to provide better care for more patients. This unique panel provides a valuable opportunity to hear first hand from industry leaders about how they, and their companies, are leading and innovating amid this pandemic.  

Guests: 

Rusty Frantz,  President and CEO, NextGen Healthcare

Phil Febbo MD, Chief Medical Officer and Sr. Vice President, Illumina 

Will Febbo, CEO, OptimizeRx 

Moderated by Rebecca Love RN, MSN, FIEL, Vice President Customer Strategy and Engagement, OptimizeRx 



Send your questions to webinars@optimizerx.com

Visit www.OptimizeRx.com/webinars for more insightful industry conversations.

Follow us on Twitter and LinkedIn